Rossari Biotech Ltd
₹437.15
+3.85 (0.89%)
Thu, 22 Oct 2026, 07:04 pm
Rossari Biotech News
Rossari Biotech Q2FY27 Results: Revenue up 19% YoY
Rossari Biotech reported a 19% YoY rise in consolidated revenue to ₹6,976 million for Q2FY27. The board also approved leasing land in Saudi Arabia for a new greenfield facility.
17 Oct 2026
companies
Rossari Biotech to host analyst meet on Sep 22
Rossari Biotech Limited will participate in the Anand Rathi Annual Flagship Conference G-200 Summit 2026 on September 22, 2026. The session will cover public financial information.
16 Sept 2026
companies
Rossari Biotech declares dividend at AGM
Rossari Biotech approved a dividend of Re. 0.50 per share and appointed directors at its 17th AGM held on July 20, 2026.
20 Jul 2026
companies
Rossari Biotech Flags El Niño Impact on Agriculture
Rossari Biotech highlights challenges in the agriculture sector due to El Niño and notes difficulty in predicting revenue and profit growth amid global uncertainty.
20 Jul 2026
companies
Rossari Biotech to host Q1 FY27 earnings call
Rossari Biotech will hold an earnings call on July 20, 2026, to discuss Q1 FY27 results declared on July 18, 2026.
14 Jul 2026
companies
Market Current News
Khazanchi Jewellers Limited
Khazanchi Jewellers gets in-principle approval for main board migration
Khazanchi Jewellers Limited received in-principle approval from BSE and NSE to migrate from the SME platform to the Main Board. The approvals are valid for 45 days.
21 Oct 2026
ipo
Core4 Engineers SME IPO: ₹285 Cr Order Book
Core4 Engineers Limited files DRHP for SME IPO. The Mysore-based EPCC firm reports ₹91.34 Cr FY26 revenue and a ₹285.83 Cr order book, seeking funds for working capital.
21 Oct 2026
ipo
SFC Env Tech IPO: ₹150 Cr Fresh Issue
SFC Environmental Technologies files DRHP for a ₹150 crore fresh issue. The Navi Mumbai-based firm holds 80% market share in SBR technology with FY26 revenue at ₹803.63 crore.
21 Oct 2026
ipo
EAAA India Alternatives IPO: ₹1,200 Cr OFS
EAAA India Alternatives files DRHP for a ₹1,200 crore Offer for Sale. No fresh issue; proceeds go to promoters. AUM stands at ₹953,448.78 million.
21 Oct 2026
ipo
Paras Healthcare IPO Day 1: Demand Sluggish at 0.08x
Paras Healthcare IPO saw weak response on Day 1 with overall subscription at 0.08x. Retail led demand at 0.41x, while QIB interest remained nil.
21 Oct 2026
ipo